News
Novartis launches once-daily COPD drug in US
www.pmlive.com
[PMLiVE] - Andre Wyss, president of Novartis' US subsidiary, said: "The launch of Arcapta Neohaler is a significant milestone as we continue to establish a strong respiratory presence in the US market." While Arcapta Neohaler is expected to have fairly modest
sorted by relevance / date